Check Claims Before You Publish

 Quick Explanation Copied

 Long Explanation

Scientific Strength of Sumeet A. Khetarpal

Citation metrics: Across 74 works indexed by OpenAlex, the author has ~2,841 citations, an h-index of 24, and sustained output from 2014 through 2026, with citation peaks in 2016–2017 (~737 and ~610 citations in those years respectively).

Key first-author contributions: The SR-BI P376L variant work in Science showed that a rare variant raising HDL cholesterol paradoxically increases coronary heart disease risk, a finding that reshaped thinking on HDL's causal role SR-BI variant Science paper. The GALNT2 loss-of-function study spanned human, nonhuman primate, and rodent data to characterize a GWAS lipid locus GALNT2 loss-of-function study, and an APOC3 missense variant plus monoclonal antibody study demonstrated accelerated apoC-III clearance lowering triglyceride-rich lipoproteins APOC3 variant and antibody study.

Collaborative reach: He contributed as a middle author to the Pakistan-based human knockout cohort study in Nature Human knockouts Nature paper and to rare lipid variant association analyses in AJHG with 56,000 individuals Rare lipid variants AJHG paper.

The 2016 review quality: The extracted Trends in Molecular Medicine review scored 8/10 on quality and 7/10 on novelty, synthesized GWAS data from >200,000 individuals, and argued triglyceride-rich lipoproteins are causal for CAD Triglyceride genetics review. Its own stated limitation is the difficulty of inferring causation from genetic associations, plus generalizability constraints from studied populations Review limitations.

Blind spots and uncertainties: Most cited works predate 2020; citation counts for 2024–2026 outputs are still accumulating and cannot yet be judged. OpenAlex lists no primary institution, and conflict-of-interest, data-availability, and funding fields are unpopulated in available data, limiting completeness of this review. Confidence in this assessment is moderate-to-high, driven by replicated top-tier publications.

 BGPT Author Review

Scientific Quality

H-index 24 with ~2,841 citations on 74 works reflects established, high-impact contributions. First-author papers on SR-BI P376L (Science, 542 citations), GALNT2 (Cell Metabolism), and APOC3 (Nature Medicine) show ability to translate human genetics into mechanistic and therapeutic insight. Strong track record in lipid genetics with publications in Science, Nature, Nature Medicine, and Cell Metabolism. Weaknesses: no independent institution listed in OpenAlex, sparse recent output on available metadata, and limited evidence of solo-driven program leadership in the provided data.

Communication Quality

The review paper synthesizes complex genetic evidence accessibly and targets therapeutic implications clearly. Work spans human, primate, and rodent models, requiring communicative bridges across disciplines. However, no communication-relevant data (writing samples, conference presence, software documentation) beyond peer-reviewed articles could be assessed.

Author Novelty

The SR-BI P376L finding directly challenged the HDL-C-CHD causal dogma, and the GALNT2/APOC3 functional genetic work opened novel therapeutic angles (glycosylation enzymes, apoC-III clearance). The Khan-reviewed triglyceride paper scored 7/10 on novelty. Novelty is high, though grounded in established human-genetics paradigms rather than wholly new methods.

Scientific Rigor

Evidence quality is strong: large-scale GWAS cohorts (>200,000 and 56,000 individuals), multispecies validation, and publication in top-tier journals with high citation counts. The provided review explicitly acknowledges its own causation and generalizability limitations. No p-hacking or reproducibility red flags appear in available metadata, but reproducibility scores were not populated, and most work was performed in large collaborations where rigor attribution is partial.